Viewing Study NCT00648804


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-01-19 @ 1:41 AM
Study NCT ID: NCT00648804
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2008-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg
Sponsor: Mylan Pharmaceuticals Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module